Beone Medicines Ltd.
ONC
$319.32-2.04 (-0.63%)
Aug 18, 2025, 4:00 PM
Financials
| 52Week High | 268.47 | 52Week Low | 138.68 |
| Beta | 0.62 | Current Ratio Annual | 1.81 |
| Current Ratio Quarterly | 1.95 | Gross Margin TTM | 84.66 |
| Market Cap | 278.12B | Net Profit Margin TTM | -10.58 |
| Operating Margin TTM | -7.30 | Price To Book | 11.03 |
| Price To Sales TTM | 9.30 | Quick Ratio Annual | 1.52 |
| Quick Ratio Quarterly | 1.66 | Return On Assets TTM | -7.59 |
| Return On Equity TTM | -12.94 | Return On Investment TTM | -9.74 |
| Revenue Growth3Y | 53.06 | Revenue Growth5Y | 55.91 |
| Revenue Growth Quarterly Yoy | 50.17 | Revenue Growth TTMYoy | 51.66 |
| Revenue Per Share TTM | 22.15 |
13F Aggregates
| Quarter | Funds | Added | Exited | Increased | Decreased | Unchanged | Shares | Value |
|---|---|---|---|---|---|---|---|---|
| Dec 31, 2024 | 228 | 3 | 0 | 5 | 4 | 1 | 43.92M | $7.52B |
| Mar 31, 2025 | 263(+15%) | 67(+2133%) | 27(+%) | 82(+1540%) | 76(+1800%) | 35(+3400%) | 42.74M(-3%) | $10.81B(+44%) |
| Jun 30, 2025 | 240(-9%) | 23(-66%) | 49(+81%) | 91(+11%) | 82(+8%) | 36(+3%) | 34.39M(-20%) | $8.03B(-26%) |